1. Home
  2. LSTA vs NTWK Comparison

LSTA vs NTWK Comparison

Compare LSTA & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • NTWK
  • Stock Information
  • Founded
  • LSTA 1980
  • NTWK 1997
  • Country
  • LSTA United States
  • NTWK United States
  • Employees
  • LSTA N/A
  • NTWK N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • LSTA Health Care
  • NTWK Technology
  • Exchange
  • LSTA Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • LSTA 20.9M
  • NTWK 56.1M
  • IPO Year
  • LSTA N/A
  • NTWK 1998
  • Fundamental
  • Price
  • LSTA $2.09
  • NTWK $4.15
  • Analyst Decision
  • LSTA Strong Buy
  • NTWK
  • Analyst Count
  • LSTA 2
  • NTWK 0
  • Target Price
  • LSTA $23.50
  • NTWK N/A
  • AVG Volume (30 Days)
  • LSTA 140.8K
  • NTWK 64.7K
  • Earning Date
  • LSTA 11-06-2025
  • NTWK 11-12-2025
  • Dividend Yield
  • LSTA N/A
  • NTWK N/A
  • EPS Growth
  • LSTA N/A
  • NTWK 316.67
  • EPS
  • LSTA N/A
  • NTWK 0.25
  • Revenue
  • LSTA $1,070,000.00
  • NTWK $66,088,229.00
  • Revenue This Year
  • LSTA N/A
  • NTWK N/A
  • Revenue Next Year
  • LSTA N/A
  • NTWK N/A
  • P/E Ratio
  • LSTA N/A
  • NTWK $15.72
  • Revenue Growth
  • LSTA N/A
  • NTWK 7.65
  • 52 Week Low
  • LSTA $1.87
  • NTWK $2.14
  • 52 Week High
  • LSTA $4.20
  • NTWK $5.75
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 35.02
  • NTWK 39.78
  • Support Level
  • LSTA $2.00
  • NTWK $3.90
  • Resistance Level
  • LSTA $2.98
  • NTWK $4.21
  • Average True Range (ATR)
  • LSTA 0.23
  • NTWK 0.26
  • MACD
  • LSTA -0.05
  • NTWK -0.05
  • Stochastic Oscillator
  • LSTA 9.18
  • NTWK 18.75

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: